During the treatment follow-up, there were highly significant differences between the level of CA9 gene expression in complete response (CR) and non-response (NR) AML patients conferring to a mean rank of 7.7 CR and 15.3 NR (p-value=0.006) ( Figure 4 ).
← all excerpts
Gene expression of carbonic anhydrase 9 (CA9) in <i>de novo</i> acute leukemia as a predictive marker for prognosis.
1
—
—